Relationship between small for gestational age and aortic intima-media thickness in newborns

Ahmad Bayu Alfarizi; Ria Nova; Julniar Mawardi Tasli; Theodorus Theodorus

doi:10.14238/pi54.1.2014.57-61

Ahmad Bayu Alfarizi Department of Child Health, Sriwijaya University Medical School
Ria Nova Department of Child Health, Sriwijaya University Medical School
Julniar Mawardi Tasli Department of Child Health, Sriwijaya University Medical School
Theodorus Theodorus Department of Child Health, Sriwijaya University Medical School

DOI: https://doi.org/10.14238/pi54.1.2014.57-61

Keywords: Small for gestational age, aortic intima-media thickness, newborns ine, sulfadoxinepyrimethamine.

Abstract

Background Small for gestational age (SGA) has been associated
with adult cardiovascular disease. Small for gestational age
newborns may undergo early aortic wall intima-media thickening
(aIMT) in utero.
Objective To determine the relationship between SGA as a risk
factor for increased aIMT, as a sign of atherosclerosis onset.
Methods We conducted a case-control study in the Neonatal Ward
and Rooming-in Nursery at Dr. Mohammad Hoesin Hospital,
Palembang, between April to June 2012. Subjects were allocated
to either the case group (aIMT 2: 0.9 mm) or to the control
group (aIMT <0.9 mm). Newborns were classified as SGA if
their birthweight (BW) was < l O'h percentile, and appropriate
for gestational age (AGA) if their BW was between lQth - 90'h
percentile, according to the Lubchenco curve. Abdominal aortic
intima-media thickness was measured by echocardiography
examination.
Results The case and control groups consisted of 30 n ewborns
each. The proportion of SGA newborns was higher in the case
group than the control group. The likelihood of infants in the case
group being SGA was significantly higher compared to the control
group, with odds ratio of 10.8 (95%CI 3,26 to 35, 72) . The mean
aIMT was significantly higher in SGA than in AGA infants, 0.9
(SD 0.16) mm vs. 0.8 (SD 0.13) mm, respectively, with a mean
difference of 0, 13 (9 5% CI 0, 050 to 0,209 mm; P"" 0,02).
Conclusion Increased aIMT is more likely found in SGA newborns.

References

Barker DJ, Eriksson JG, Forsen T, Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol. 2002;31:1235-9.

Hay WW, Thureen PJ, Anderson MS. Intrauterine growth restriction. Neoreviews. 2001;2:129-37.

Skilton MR, Evans N, Griffiths KA, Harmer JA, Celermajer DS. Aortic wall thickness in newborns with intrauterine growth restriction. Lancet. 2005;365:1484-6.

Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull. 2001;60:5-20.

Zanardo V, Fanelli T, Weiner G, Fanos V, Zaninotto M, Visentin S, et al. Intrauterine growth restriction is associated with persistent aortic wall thickening and glomerular proteinuria during infancy. Kidney Int. 2011;80:119-23.

Barker DJ. In utero programming of chronic disease. Clin Sci. 1998;95:115-28.

Cosmi E, Visentin S, Fanelli T, Mautone AJ, Zanardo V. Aortic intima media thickness in fetuses and children with intrauterine growth restriction. Obstet Gynecol. 2009;114:1109-14.

Saleem T, Sajjad N, Fatima S, Habib N, Ali SR, Qadir M. Intrauterine growth retardation-small events, big cons equencies. Ital J Pediatr. 2011;37:41.

Pesonen E, Johnsson J, Berg A. Intimal thickness of the coronary arteries in low-birthweight infants. Acta Paediatr. 2006;95:1234-8.

Simmons R. Fetal origins of adult disease: concepts and controversies. Neoreviews. 2004;5:511-5.

Warshaw JB. Intrauterine growth retardation. Pediatr Rev. 1986;8:107-14.

Resnik R. Intrauterine growth restriction. Obstet Gynecol. 2002;99:490-6.

Belay B, Belamarich P, Racine AD. Pediatric precursors of adult atherosclerosis. Pediatr Rev. 2004;25:4-16.

Skilton MR. Intrauterine risk factors for precocious atherosclerosis. Pediatrics. 2008;121:570-4.

Khanna SB, Dash K, Swasti, Dwivedee K. Fetal origin of adult disease. JK Science. 2007;9:206-10.

Lucas A. Programming by early nutrition: an experimental approach. J Nutt. 1998;128:401-6.

Leeson CP, Kattenhorn M, Morley R, Lucas A, Deanfield JE. Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation. 2001;103:1264-8.

Napoli C, Lerman LO, de Nigris F, Gossi M, Balestriere ML, Lerman A. Rethinking primary prevention of atherosclerosisrelated diseases. Circulation. 2006;114:2517-27.

Prentice AM, Moore SE. Early programming of adult diseases in resource poor countries. Arch Dis Child. 2005;90:429-32.

Skilton MR, Viikari JS, Juonala M, Laitinen T, Lehtirnki T, Taittonen L, et al. Fetal growth and preterm birth influence cardiovascularrisk factors and arterial health in young adults: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vase Biol. 2011;31:2975-81.

Handy DE, Castro R, Loscalzo J. Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation. 2011;123:2145-56.

Rodondi N, Marques-Vidal P, Butler J, Sutton-Tyrell K, Cornuz J, Satterfield S, et al. Markers of atherosclerosis and inflammation for prediction of coronary heart disease in older adults. AmJ Epidemiol. 2010;171:540-9.

Neitzke U, Harder T, Plagemann A. Intrauterine growth restriction and developmental programming of the metabolic syndrome: a critical appraisal. Microcirculation. 2011;18:304-11.

Chatelain P. Children born with intra-uterine growth retardation (IUGR) or small for gestational age (SGA): long term growth and metabolic consequences. Endocr Regul. 2000;33:33-6.

Brodszki J, Uinne T, Marsal K, Ley D. Impaired vascular growth in late adolescence after intrauterine growth restriction. Circulation. 2005;111:2623-8.

Crispi F, Bijnens B, Figueras F, Bartrons J, Eixarch E, Ahmed A, et al. Fetal growth restriction results in remodeled and less efficient hearts in children. Circulation. 2010;121:2427-36.

Joseph KS, Kramer MS. Review of the evidence on fetal and early childhood antecedents of adult chronic disease. Epidemiol Rev. 1996;18:158-74.

Lucas A, Fewtrell MS, Cole TJ. Fetal origins of adult diseasethe hypothesis revisited. BMJ. 1999;319:245-9.

Koklu, Ozturk MA, Gunes T, Akcakus M, Kurtoglu S. Is increased intima-media thickness associated with preatherosclerotic changes in intrauterine growth restricted newborns? Acta Pediatr. 2007;9 6:1855-62.

Koklu E, Kurtoglu S, Akcakus M, Yikilmaz A, Coskun A, Gunes T. Intima-media thickness of the abdominal aorta of neonate with different gestational ages. J Clin Ultrasound. 2007;35:491-7.

Ikari Y, McManus BM, Kenyon J, Scwhartz SM. Neonatal intima formation in the human coronary artery. Arterioscler Thromb Vase Biol. 1999;19:2036-40.

Litwin M, Niemirska A. Intima-media thickness measurements in children with cardiovascular risk factors. Pediatr Nephrol. 2009;24:707-19.

Lo Vasco VR, Salmaso R, Zanardo V, Businaro R, Visentin S, Trevisanuto D, et al. Fetal aorta wall inflammation in ultrasound-detected aortic intima/media thickness and growth retardation. J Reprod Immunol. 2011;91:103-7.

Dahlen EM, Andreassen T, Cinthia M, Nystrom FH, Ostgren CJ, Lanne T. Is there an underestimation of intima-media thickness based on M-mode ultrasound technique in the abdominal aorta? Clin Physiol Funct Imaging. 2012;32:1-4.

Ley D, Stale H, Marsal K. Aortic vessel wall characteristics and blood pressure in children with intrauterine growth retardation and abnormal foetal aortic blood flow. Acta Paediatr. 1997;86:299-305.

Sattar N, McConnachie A, O'Reilly D, Upton MN, Greer IA, Davey G, et al. Inverse association between birth weight and C-reactive protein concentrations in the MIDSPAN Family Study. Arterioscler Thromb Vase Biol. 2004;24:583-7.

Zieske AW, Tracy RP, McMahan CA, Herderick EE, Homma S, Malcolm GT, et al. Elevated serum C-reactive protein levels and advanced atherosclerosis in youth. Arterioscler Thromb Vase Biol. 2005;25:1237-43.

Radunovic N, Kuczynski E, Rosen T, Dukanac J, Petkovic S, Lockwood CJ. Plasma apolipoprotein A-I and B concentrations in growth-retarded fetuses: a link between low birth weight and adult atherosclerosis. J Clin Endocrinol Metab. 2000;85:85-8.

Arima H, Kubo M, Yonemoto K, Doi Y, Ninomiya T, Tanizaki Y, et al. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler Thromb Vase Biol. 2008;28:1385-91.

Leduc L, Levy E, Bouity-Voubou M, Delvin E. Fetal programming of atherosclerosis: possible role of the mitochondria. Eur J Obstet Gynecol Reprod Biol. 2010;149:127-30.

Charakida M, Deanfield JE. M yeloperoxidas e expression in early life. On the causal pathways for atherosclerosis? Atherosclerosis. 2009;205:37-8.

Anand SS, Razak F, Yi Q, Davis B, Jacobs R, Vuksan V, et al. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vase Biol. 2004;24:1509-15.

Lottenberg SA, Glezer A, Turatti LA. Metabolic syndrome: identifying the risk factors. J Pediatr. 2007;83:204-8.

Akisu M, Balim Z, Cetin H, Kosova B, Yalaz M, Topcuoglu N, et al. The role of angiotensin-converting enzyme and apolipoprotein-E gene polymorphisms on lipid compositions in newborn infants with intrauterine growth restriction. Early Hum Dev. 2004;78:95-103.

Corrado E, Rizzo M, Coppola G, Fattouch K, Novo G, Marturana I, et al. An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb. 2010;17:1-11.